These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15139522)

  • 1. Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line.
    Jeong WS; Kim IW; Hu R; Kong AN
    Pharm Res; 2004 Apr; 21(4):649-60. PubMed ID: 15139522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway.
    Jeong WS; Kim IW; Hu R; Kong AN
    Pharm Res; 2004 Apr; 21(4):661-70. PubMed ID: 15139523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
    Nair S; Hebbar V; Shen G; Gopalakrishnan A; Khor TO; Yu S; Xu C; Kong AN
    Pharm Res; 2008 Feb; 25(2):387-99. PubMed ID: 17657594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
    Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells.
    Gopalakrishnan A; Xu CJ; Nair SS; Chen C; Hebbar V; Kong AN
    Arch Pharm Res; 2006 Aug; 29(8):633-44. PubMed ID: 16964758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-jun/AP-1 activation does not affect the antiproliferative activity of phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent.
    Yao S; Zhang Y; Li J
    Mol Carcinog; 2006 Aug; 45(8):605-12. PubMed ID: 16652374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
    Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
    Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
    Chung JY; Huang C; Meng X; Dong Z; Yang CS
    Cancer Res; 1999 Sep; 59(18):4610-7. PubMed ID: 10493515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
    Tsai TF; Chen PC; Lin YC; Chou KY; Chen HE; Ho CY; Lin JF; Hwang TI
    Environ Toxicol; 2020 Jan; 35(1):47-54. PubMed ID: 31587482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways.
    Yu R; Hebbar V; Kim DW; Mandlekar S; Pezzuto JM; Kong AN
    Mol Pharmacol; 2001 Jul; 60(1):217-24. PubMed ID: 11408617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of c-Jun-N-terminal-kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers.
    Grösch S; Tegeder I; Schilling K; Maier TJ; Niederberger E; Geisslinger G
    FASEB J; 2003 Jul; 17(10):1316-8. PubMed ID: 12759338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction events elicited by cancer prevention compounds.
    Kong AN; Yu R; Hebbar V; Chen C; Owuor E; Hu R; Ee R; Mandlekar S
    Mutat Res; 2001 Sep; 480-481():231-41. PubMed ID: 11506817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of food factors on signal transduction pathways.
    Dong Z
    Biofactors; 2000; 12(1-4):17-28. PubMed ID: 11216482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of activator protein 1 activity by glycyrrhizin.
    Hsiang CY; Lai IL; Chao DC; Ho TY
    Life Sci; 2002 Feb; 70(14):1643-56. PubMed ID: 11991252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells.
    Wang L; Zhang Y; Li H; Xu Z; Santella RM; Weinstein IB
    Cancer Res; 2007 May; 67(10):4700-8. PubMed ID: 17510397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif.
    Luo Y; Hao Y; Shi TP; Deng WW; Li N
    Acta Pharmacol Sin; 2008 May; 29(5):628-33. PubMed ID: 18430372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying effects of dietary factors on (-)-epigallocatechin-3-gallate-induced pro-matrix metalloproteinase-7 production in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Ohigashi H
    Biosci Biotechnol Biochem; 2007 Oct; 71(10):2442-50. PubMed ID: 17928719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC).
    Keum YS; Owuor ED; Kim BR; Hu R; Kong AN
    Pharm Res; 2003 Sep; 20(9):1351-6. PubMed ID: 14567627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.